Ebola reaches France past exit checks

Exit screening's structural ceiling rests on a biological fact: Bundibugyo ebolavirus has an incubation period of up to 21 days, and viral load in blood is too low to detect by rapid antigen test until the patient develops fever and symptoms.

DRC's exit screening protocol checks temperature and symptom self-declaration, two measures that are valid only when the infection has progressed to clinical illness. A health worker WHO deployed for 31 days in Ituri Province, completed their tour, and departed 19 June was within the incubation window but pre-symptomatic; the protocol had no mechanism to catch them.

The secondary structural cause is the absence of a mandatory post-departure monitoring regime for healthcare workers deployed in active PHEIC zones. France has had the capacity for 21-day active surveillance since the 2014-16 outbreak, but deployment remained voluntary rather than required under French public health law. The gap between voluntary and mandatory was closed in the UK (UKHSA issued mandatory 21-day monitoring notices for Ebola returnees) but persists across much of the EU.

The France importation is a qualitative escalation: the first confirmed Ebola case outside Africa in this PHEIC. It does not alter the outbreak's fundamental trajectory inside DRC. ECDC's maintained 'very low' EU/EEA risk assessment reflects Bundibugyo's limited secondary transmission potential outside a healthcare setting.

The more significant escalation signal remains the declining isolation rate inside DRC (from 45.9% on 14 June to 35% on 23 June), which drives CDC model projections toward worst-case outcomes. The France case is a demonstration of the importation risk documented by prior WHO risk assessments, not a new threat vector.